{"id":"W4387130385","doi":"10.1038/s41591-023-02561-8","title":"Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Heterotopic Ossification and Related Conditions","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"National Center for Advancing Translational Sciences; Georgia Clinical and Translational Science Alliance; Ipsen; Regeneron Pharmaceuticals; Vanderbilt University; University of Pennsylvania; Vanderbilt University Medical Center","keywords":"Fibrodysplasia ossificans progressiva; Double blind; Medicine; Placebo; Randomized controlled trial; Internal medicine; Surgery; Heterotopic ossification; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001529497,0.001817785,0.002854685,0.0005762178,0.0003501173,0.001001515,0.0008695626,0.002604244,0.006565475],"category_scores_gemma":[0.001603206,0.000624734,0.0016343,0.0003470023,0.0009035754,0.001022717,0.0003323646,0.002672889,0.0009806887],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003947299,"about_ca_system_score_gemma":0.0007776431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003055848,"about_ca_topic_score_gemma":0.00066204,"domain_scores_codex":[0.9994894,0.0002621402,0.00002470524,0.00008750551,0.00004655394,0.00008969631],"domain_scores_gemma":[0.999393,0.0002113001,0.0001303566,0.00004353285,0.00004629595,0.0001755145],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.95826,0.01078399,0.0003332541,0.001474941,0.000641447,0.00009385923,0.00005403557,0.0003004461,0.004079486,0.0001818685,0.0009499647,0.02284673],"study_design_scores_gemma":[0.9632082,0.03520587,0.0004978285,0.00003566675,0.0001365974,0.00003079884,0.000008300414,0.0001773692,0.0001818127,0.00008004473,0.0004311228,0.000006361739],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9713829,0.01443604,0.001091736,0.001174535,0.0009951432,0.006670482,0.001149493,0.0003043796,0.002795227],"genre_scores_gemma":[0.9664332,0.009390322,0.002725593,0.002225123,0.0009975241,0.01187985,0.001516685,0.00004943693,0.004782443],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006565475,"threshold_uncertainty_score":0.02196372,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03778756913034265,"score_gpt":0.3917778725754334,"score_spread":0.3539903034450907,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}